Miley Sawyer

Pharmacist



  
  740 S Limestone Ste J301, Lexington
Kentucky, 40536-0001

 859-323-1691    859-323-1700
Miley Sawyer is a pharmacist in Lexington, Kentucky. Patients can reach her at 740 S Limestone Ste J301, Lexington or contact her on 859-323-1691. Active license number of Miley Sawyer is 021803 for Pharmacist in Kentucky.
Miley Sawyer is


Complete Profile:
Miley Sawyer speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name: Miley Sawyer
Specialization: Pharmacist
Credentials:PHARMD
Gender:Female
Location:740 S Limestone Ste J301, Lexington,
Kentucky, 40536-0001
Phone:859-323-1691
Fax:859-323-1700
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Miley Sawyer are as mentioned below.
NPI Number: 1821715475
NPI Enumeration Date: 25 Oct, 2022
NPI Last Update On: 29 Sep, 2025

Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Miley Sawyer are as mentioned below.
SpecializationLicense NumberStateStatus
Pharmacist 021803KentuckyPrimary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: 740 S Limestone Ste J301,
Lexington, Kentucky
Zip: 40536-0001
Phone Number: 859-323-1691
Patients can reach Miley Sawyer at 740 S Limestone Ste J301, Lexington, Kentucky or can call on phone at 859-323-1691.

Comments/ Reviews:
Read all the reviews posted for Miley Sawyer below. You may also share your own experience with Miley Sawyer. Your feedback can help others make better decisions.
**Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 08 December, 2025.